Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Ensysce Biosciences To Exercise Certain Outstanding Warrants To Purchase Up To An Aggregate Of 630,376 Shares Of Common Stock Of The Company Originally Issued In March 2025, Having An Exercise Price Of $3.24 Per Share

Author: Benzinga Newsdesk | April 23, 2025 04:46pm

Posted In: ENSC